Clinical trial · Observational
Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer
Correlation Between Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer
NCT02879968CI-TRIAL-00043797completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Correlation between serum squamous cell carcinoma antigen level and tumor volume in Head and Neck Cancer is to determine a correlation between level of serum squamous cell carcinoma antigen and tumor volume in Head and Neck Caner measured by cross-sectional imaging.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-interventional study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Head and Neck squamous cell carcinoma
- description
- A single measurement of serum squamous cell carcinoma antigen level is performed in the eligible Head and Neck squamous cell carcinoma patients. The study tool measuring serum squamous cell carcinoma antigen level is ARCHITECT SCC (Abbott). The gross tumor volume in the cross sectional imaging obtained within 2 weeks of each patient is calculated with the typical ellipsoid formula.
- interventionNames
- Other: Non-interventional study
Primary outcomes (1)
- measure
- Correlation between serum squamous cell carcinoma antigen and tumor volume
- timeFrame
- 2 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven squamous cell carcinoma in Head and Neck * Getting a cross-sectional imaging of Head and Neck within 2 weeks of collecting serum squamous cell carcinoma antigen Exclusion Criteria: * Metastatic disease * Accompanied Non-Head and Neck squamous cell carcinoma * Nasopharyngeal, thyroid, salivary, nose and paranasal sinus carcinoma * Skin disease: eczema, erythrodermic epidermitis, pemphigus, and psoriasis * Pulmonary disease: tuberculosis, adult respiratory distress syndrome, pulmonary infiltration with eosinophilia, sarcoidosis, and bronchogenic cyst * Renal failure * Using antihistamine eye drops
References
Publications (0)
Data not yet available
No reference posted for this study.